Time trends of cancer incidence and mortality in Catalonia during 1993-2007

Clinical and Translational Oncology

Volumn 16, Issue 1, 2014, Pages 18-28

  Cleries R ^a,b   Esteban, L ^a   Borras J ^c,d   Marcos Gragera, R ^e,f,g   Freitas, A ^h   Carulla, M ^c   Buxo M ^e,f   Puigdefabregas A ^h   Izquierdo, A ^e,f   Gispert, R ^h   Galceran, J ^c   Ribes, J ^a,b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Fundació Lliga per A la Investigació i Prevenció Del Càncer ^*  (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g UNIVERSITY OF GIRONA   (Spain)

^h Servei d'Informació i Estudis   (Spain)

Author keywords

Cancer; Incidence; Modeling; Mortality; Time trends

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; MOUTH CANCER; MULTIPLE MYELOMA; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PENIS CANCER; PHARYNX CANCER; PREVALENCE; PROSTATE CANCER; SMOKING; SPAIN; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERUS CANCER; VERY ELDERLY;

AGE DISTRIBUTION; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; SPAIN; TIME FACTORS;

EID: 84893726671     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1060-y     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765-81.
3. Cleries R, Ribes J, Buxo M, Ameijide A, Marcos-Gragera R, Galceran J, et al. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med. 2012;10(31):978-87.
4. Ribes J, Cleries R, Buxo M, Ameijide A, Valls J, Gispert R. Predictions of cancer incidence and mortality in Catalonia to 2015 by means of Bayesian models]. Med Clin (Barc). 2008;131(Suppl 1):32-41.
5. Sanchez MJ, Payer T, De Angelis R, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012. Ann Oncol. 2010;05(Suppl 3:iii):30-6.
6. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al, editors. Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC Scientific Publications; 2007.
7. World Health Organization. International Classification of Diseases, ninth revision. Geneva: WHO; 1977.
8. World Health Organization. International Statistical Classification of Diseases and Related Health problems, tenth revision. Geneva: WHO; 1992.
9. Esteban L, Cleries R, Galvez J, Pareja L, Escriba JM, Sanz X, et al. REGSTATTOOLS: freeware statistical tools for the analysis of disease population databases used in health and social studies. BMC Public Health. 2013;13(1):201.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: gLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
11. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403.
12. Malvezzi M, Bertuccio P, Levi F, la Vecchia C, Negri E. European cancer mortality predictions for the year 2012. Ann Oncol. 2013;24(3):792-800.
13. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079-92.
14. Izquierdo A, Gispert R, Saladie F, Espinas JA. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: breast cancer. Med Clin (Barc). 2008;131(Suppl 1):50-2.
15. Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J, et al. Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst. 2009;101(22):1584-91.
16. Cleries R, Martinez JM, Moreno V, Yasui Y, Ribes J, Borras JM. Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach. Epidemiology. 2013;24(3):454-60.
17. Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, la Vecchia C. The decline in breast cancer mortality in Europe: an update (to 2009). Breast. 2012;21(1):77-82.
18. Ribes J, Navarro M, Cleries R, Esteban L, Pareja L, Binefa G, et al. Colorectal cancer mortality in Spain: trends and projections for 1985-2019. Eur J Gastroenterol Hepatol. 2009;21(1):92-100.
19. Borras JM, Pareja L, Peris M, Espinas JA. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: colorectal cancer. Med Clin (Barc). 2008;131(Suppl 1):58-62.
20. Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol. 2011;37(4):325-33.
21. Malvezzi M, Bosetti C, Rosso T, Bertuccio P, Chatenoud L, Levi F, et al. Lung cancer mortality in European men: trends and predictions. Lung Cancer. 2013;80(2):138-45.
22. Borras JM, Pinol JL, Izquierdo A, Borras J. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: lung cancer. Med Clin (Barc). 2008;131(Suppl 1):53-7.
23. Schiaffino A, Fernandez E, Kunst A, Borrell C, Garcia M, Borras JM, et al. Time trends and educational differences in the incidence of quitting smoking in Spain (1965-2000). Prev Med. 2007;45(2-3):226-32.
24. Lopez MJ, Fernandez E, Perez-Rios M, Martinez-Sanchez JM, Schiaffino A, Galan I, et al. Impact of the 2011 Spanish smoking ban in hospitality venues: indoor secondhand smoke exposure and influence of outdoor smoking. Nicotine Tob Res. 2013;15(5):992-6.
25. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289-93.
26. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borras J, Cleries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24(9):1083-8.
27. Marcos-Gragera R, Pollan M, Chirlaque MD, Guma J, Sanchez MJ, Garau I, et al. Attenuation of the epidemic increase in non-hodgkin's lymphomas in Spain. Ann Oncol. 2010;21(Suppl 3:iii):90-6.
28. Clèries R, Martínez JM, Escribà JM, Esteban L, Pareja L, Borràs JM, et al. Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005-2019 through a Bayesian approach. Cancer Epidemiology. 2010;34(3):244-56.
29. Ribes J, Pareja L, Esteban L, Cleries R. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: liver cancer. Med Clin (Barc). 2008;131(Suppl 1):83-7.
30. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14(9):2191-9.